Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canel, M.
Right arrow Articles by Chiara, M.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canel, M.
Right arrow Articles by Chiara, M.-D.
Related Collections
Right arrowCommentary
Clinical Cancer Research Vol. 12, 3272-3279, June 1, 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number

Marta Canel1,3, Pablo Secades1,3, Juan-Pablo Rodrigo1,3, Rubén Cabanillas1,3, Agustín Herrero2,3, Carlos Suarez1,3 and María-Dolores Chiara1,3

Authors' Affiliations: 1 Servicio de Otorrinolaringología y, 2 Anatomía Patológica del Hospital Universitario Central de Asturias, and 3 Instituto Universitario de Oncologia del Principado de Asturias, Universidad de Oviedo, Spain

Requests for reprints: María Dolores Chiara, Departamento de Cirugía y Especialidades, Facultad de Medicina, 6a planta, C/Julian Clavería s/n, E-33006-Oviedo, Asturias, Spain. Phone: 34-985-103589; Fax: 34-985-104198; E-mail: mdchiara.uo{at}uniovi.es.

The development of human malignancies can involve the aberrant regulation of intracellular signal transduction pathways that regulate cell-extracellular matrix interactions.

Purpose: In the current study, we aimed to evaluate focal adhesion kinase (FAK) at both genetic and protein expression levels in head and neck squamous cell carcinomas (HNSCC) and to explore the prognostic significance of FAK.

Experimental Design: A total of 211 tissue specimens, including 147 primary tumors, 56 lymph node metastases, 3 benign hyperplasias, and 5 dysplasias, were analyzed using immunohistochemistry. The fak gene dosage was determined in 33 tumors. Correlations among DNA, protein, and clinicopathologic variables were analyzed.

Results: FAK protein was overexpressed in HNSCCs compared with corresponding normal mucosa. High expression levels were found in 62% of the samples. Positive immunostaining was also detected in benign hyperplasias and preinvasive dysplastic lesions. All lymph node metastases examined showed FAK overexpression, with significant correlation with the expression in matched primary tumor. DNA copy number ratios for fak were higher in 39% of the tumors compared with normal mucosa. However, elevated FAK expression did not correlate with gains on DNA level, and not all cases with an amplification of the fak gene displayed protein overexpression. Similar data were obtained in five HNSCC-derived cell lines, in which FAK mRNA levels were precisely correlated with FAK protein levels. FAK protein overexpression in tumors correlated with nodal metastases.

Conclusions: These findings suggest an involvement of FAK in the onset and progression of HNSCC and provide an insight into a mechanism of FAK activation alternative to gene amplification.


Commentary

The Signaling and Biological Implications of FAK Overexpression in Cancer
Priscila M.F. Siesser and Steven K. Hanks
Clin. Cancer Res. 2006 12: 3233-3237. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Schwock, N. Dhani, M. P.-J. Cao, J. Zheng, R. Clarkson, N. Radulovich, R. Navab, L.-C. Horn, and D. W. Hedley
Targeting Focal Adhesion Kinase with Dominant-Negative FRNK or Hsp90 Inhibitor 17-DMAG Suppresses Tumor Growth and Metastasis of SiHa Cervical Xenografts
Cancer Res., June 1, 2009; 69(11): 4750 - 4759.
[Abstract] [Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
H. K. Gan and L. L. Siu
Focal Adhesion Kinase as a Therapeutic Target in Cancer
ASCO Educational Book, January 1, 2009; 2009(1): 130 - 136.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. A. Beierle, N. A. Massoll, J. Hartwich, E. V. Kurenova, V. M. Golubovskaya, W. G. Cance, P. McGrady, and W. B. London
Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses
Clin. Cancer Res., June 1, 2008; 14(11): 3299 - 3305.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. T. Parsons, J. Slack-Davis, R. Tilghman, and W. G. Roberts
Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention
Clin. Cancer Res., February 1, 2008; 14(3): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
J. P. Rodrigo, F. Dominguez, V. Suarez, M. Canel, P. Secades, and M. D. Chiara
Focal Adhesion Kinase and E-Cadherin as Markers for Nodal Metastasis in Laryngeal Cancer
Arch Otolaryngol Head Neck Surg, February 1, 2007; 133(2): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. M.F. Siesser and S. K. Hanks
The Signaling and Biological Implications of FAK Overexpression in Cancer.
Clin. Cancer Res., June 1, 2006; 12(11): 3233 - 3237.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.